반응식
[CH3:1][CH:2]([CH3:19])[CH2:3][C:4]1[NH:5][C:6]2[C:11]([CH:12]=1)=[C:10]([C:13]([F:16])([F:15])[F:14])[C:9]([C:17]#[N:18])=[CH:8][CH:7]=2.[F:20][C:21]([F:36])([F:35])[C:22]1[CH:23]=[C:24]([C:28]2[O:32][N:31]=[C:30]([CH2:33]Cl)[N:29]=2)[CH:25]=[CH:26][CH:27]=1>>[CH3:1][CH:2]([CH3:19])[CH2:3][C:4]1[N:5]([CH2:33][C:30]2[N:29]=[C:28]([C:24]3[CH:25]=[CH:26][CH:27]=[C:22]([C:21]([F:36])([F:20])[F:35])[CH:23]=3)[O:32][N:31]=2)[C:6]2[C:11]([CH:12]=1)=[C:10]([C:13]([F:16])([F:14])[F:15])[C:9]([C:17]#[N:18])=[CH:8][CH:7]=2참가 물질
3
반응물 2
생성물 1
실험 절차
Synthesized as described in Example 4 using 2-(2-methylpropyl)-4-(trifluoromethyl)-1H-indole-5-carbonitrile and 5-[3-(trifluoromethyl)phenyl]-3-(chloromethyl)-1,2,4-oxadiazole: 1H NMR (400 MHz, CDCl3) δ 8.30 (s, 1H), 8.22 (d, J=7.8 Hz, 1H), 7.85 (d, J=7.8 Hz, 1H), 7.66 (m, 2H), 7.54 (d, J=8.3 Hz, 1H), 6.63 (d, J=1.2 Hz, 1H), 5.48 (s, 2H), 2.84 (d, J=7.3 Hz, 2H), 2.14 (m, 1H), 1.08 (d, J=6.6 Hz, 6H); MS (ES) m/z 493 (M+1).
후처리
- customSynthesized
출처 및 근거
- ORD 기록
- ord-6281e92d00ba41809392c040b9564575
- 출처 데이터셋
- uspto-grants-2011_09
- 특허 번호
- US08026262B2
연결된 노트
불러오는 중…